A SINGLE drug has been found to inhibit a range of common viruses in lab studies, including coronaviruses, respiratory syncytial virus (RSV), norovirus, and influenza and hepatitis viruses. It will be tested in a clinical trial next year, raising hopes that the pill could one day be taken at home to relieve unpleasant symptoms.
“As far as we can tell, this is the first drug that’s ever demonstrated activity across all these viral families,” says Daniel Haders, co-founder of Model Medicines, the California-based company leading its development. If it is approved, Haders envisages it being a pill that people could take if, for example, they have a flu-like illness but don’t know if it is influenza, covid-19, RSV or something else.
The drug was originally developed as a breast cancer…